Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về sinh học được đăng trên tạp chí hóa học quốc tế đề tài : Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome | BioMed Central Health and Quality of Life Outcomes Research Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome Carolyn E Schwartz 1 2 3 Julia F Martha1 Paulette Kowalski1 David A Wang1 Rita Bode4 Ling Li1 and David H Kim1 2 Address Department of Orthopedics New England Baptist Hospital Boston Masschusetts USA - Departments of Medicine and Orthopaedic Surgery Tufts School of Medicine Boston Massachusetts USA 3DeltaQuest Foundation Inc. Concord Massachusetts USA and 4Department of Physical Medicine Rehabilitation Feinberg School of Medicine Northwestern University Chicago Illinois USA Email Carolyn E Schwartz - carolyn.schwartz@deltaquest.org Julia F Martha - jmartha@caregroup.harvard.edu Paulette Kowalski - walsk18@yahoo.com David A Wang - davidaxwang@gmail.com Rita Bode - r-bode@comcast.net Ling Li - lli7@caregroup.harvard.edu David H Kim - dhkim@caregroup.harvard.edu Corresponding author Open Access Published 29 May 2009 Received 25 March 2009 Health and Quality of Life Outcomes 2009 7 49 doi 10.1186 1477-7525-7-49 Accepted 29 May 2009 This article is available from http www.hqlo.cOm content 7 1 49 2009 Schwartz et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Autogenous Iliac Crest Bone Graft ICBG has been the gold standard for spinal fusion. However bone graft harvest may lead to complications such as chronic pain numbness and poor cosmesis. The long-term impact of these complications on patient function and well-being has not been established but is critical in determining the value of expensive bone graft substitutes such as recombinant bone morphogenic protein. We thus aimed to investigate the .
